Literature DB >> 17906704

Thiotepa-based reduced intensity conditioning regimen: a 10 year follow up.

A Bacigalupo, A M Raiola, T Lamparelli, F Gualandi, D Occhini, S Bregante, A Ibatici, C di Grazia, A Dominietto, B Bruno, M T Van Lint, F Frassoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17906704     DOI： 10.1038/sj.bmt.1705863

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT.

Authors:  S Eder; M Labopin; J Finke; D Bunjes; A Olivieri; S Santarone; A Rambaldi; L Kanz; G Messina; M Mohty; A Nagler
Journal:  Bone Marrow Transplant       Date:  2016-09-19       Impact factor: 5.483

2.  Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients.

Authors:  Alexandros Spyridonidis; Myriam Labopin; Bipin N Savani; Riitta Niittyvuopio; Didier Blaise; Charles Craddock; Gerard Socié; Uwe Platzbecker; Dietrich Beelen; Noel Milpied; Jan J Cornelissen; Arnold Ganser; Anne Huynh; Laimonas Griskevicius; Sebastian Giebel; Mahmoud Aljurf; Eolia Brissot; Florent Malard; Jordi Esteve; Zinaida Peric; Frédéric Baron; Annalisa Ruggeri; Christoph Schmid; Maria Gilleece; Norbert-Claude Gorin; Francesco Lanza; Roni Shouval; Jurjen Versluis; Gesine Bug; Yngvar Fløisand; Fabio Ciceri; Jamie Sanz; Ali Bazarbachi; Arnon Nagler; Mohamad Mohty
Journal:  Bone Marrow Transplant       Date:  2020-01-29       Impact factor: 5.483

3.  Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend "when and for whom" in 2021?

Authors:  Nico Gagelmann; Nicolaus Kröger
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.